Cargando…
Lack of Ovarian Secretions Reverts the Anabolic Action of Olanzapine in Female Rats
BACKGROUND: Olanzapine is an orexigenic antipsychotic drug associated with serious metabolic adverse effects in humans. Development of valid rodent models for antipsychotic-induced metabolic adverse effects is hampered by the fact that such effects occur in females only. Estradiol is a predominant f...
Autores principales: | Skrede, Silje, González-García, Ismael, Martins, Luís, Berge, Rolf Kristian, Nogueiras, Ruben, Tena-Sempere, Manuel, Mellgren, Gunnar, Steen, Vidar Martin, López, Miguel, Fernø, Johan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5716078/ https://www.ncbi.nlm.nih.gov/pubmed/29020342 http://dx.doi.org/10.1093/ijnp/pyx073 |
Ejemplares similares
-
Olanzapine-Induced Hyperphagia and Weight Gain Associate with Orexigenic Hypothalamic Neuropeptide Signaling without Concomitant AMPK Phosphorylation
por: Fernø, Johan, et al.
Publicado: (2011) -
One-Year Treatment with Olanzapine Depot in Female Rats: Metabolic Effects
por: Ersland, Kari M, et al.
Publicado: (2019) -
Lipid-Lowering Effects of Tetradecylthioacetic Acid in Antipsychotic-Exposed, Female Rats: Challenges with Long-Term Treatment
por: Skrede, Silje, et al.
Publicado: (2012) -
Subchronic olanzapine exposure leads to increased expression of myelination-related genes in rat fronto-medial cortex
por: Ersland, Kari M., et al.
Publicado: (2017) -
Psychotropic drugs up-regulate the expression of cholesterol transport proteins including ApoE in cultured human CNS- and liver cells
por: Vik-Mo, Audun O, et al.
Publicado: (2009)